Urinary Exosomes as Markers in Prostate Cancer Treatment
Author Information
Author(s): Mitchell Paul J, Welton Joanne, Staffurth John, Court Jacquelyn, Mason Malcolm D, Tabi Zsuzsanna, Clayton Aled
Primary Institution: Cardiff University, Velindre Cancer Centre
Hypothesis
Can urinary exosomes act as treatment response markers in prostate cancer?
Conclusion
Urinary exosomes show variability in quantity and quality, but they may provide useful non-invasive markers for prostate cancer.
Supporting Evidence
- Urinary exosome levels decreased by approximately 2-fold after 3 months of androgen deprivation therapy.
- PSA and PSMA were detected in 20 of 24 prostate cancer specimens but not in healthy donors.
- The study provides the first evidence suggesting urinary exosomes may be useful for monitoring prostate cancer treatment.
Takeaway
Doctors are looking at tiny bubbles in urine called exosomes to see how well prostate cancer treatment is working.
Methodology
Ten prostate cancer patients provided urine samples at three time points during treatment, and exosomes were analyzed for prostate markers.
Potential Biases
Potential biases may arise from the small sample size and variability in exosome content among patients.
Limitations
The study faced challenges with variability in exosome quantity and quality, making it difficult to draw definitive conclusions.
Participant Demographics
Ten prostate cancer patients and ten healthy male volunteers were included.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website